Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ramanoelina

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue Neurologique|October 31, 2002
[Central nervous system and systemic vasculitides]L Guillevin, J Ramanoelina, A Mahr
La Revue De Medecine Interne|November 26, 1999
[Systemic reaction induced my minocycline treatment: a report of four patients and a review of the literature]A M Piette, J Ramanoelina, P Gepner, et al.
Rheumatology (Oxford, England)|October 5, 2002
Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patientsP Bartolucci, J Ramanoelina, P Cohen, et al.
Rheumatology (Oxford, England)|June 5, 2003
Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unitB A Cruz, J Ramanoelina, A Mahr, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue Neurologique|October 31, 2002
[Central nervous system and systemic vasculitides]L Guillevin, J Ramanoelina, A Mahr
La Revue De Medecine Interne|November 26, 1999
[Systemic reaction induced my minocycline treatment: a report of four patients and a review of the literature]A M Piette, J Ramanoelina, P Gepner, et al.
Rheumatology (Oxford, England)|October 5, 2002
Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patientsP Bartolucci, J Ramanoelina, P Cohen, et al.
Rheumatology (Oxford, England)|June 5, 2003
Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unitB A Cruz, J Ramanoelina, A Mahr, et al.
Pageof 1